nefiracetam has been researched along with Age-Related Memory Disorders in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukunaga, K; Han, F; Moriguchi, S; Nakagawasai, O; Nakajima, T; Narahashi, T; Shioda, N; Tadano, T; Yamamoto, Y; Yeh, JZ | 1 |
Ando, T; Fukatsu, T; Miyake-Takagi, K; Nagakura, A; Niimura, M; Takagi, N; Takeo, S; Tanonaka, K | 1 |
Ando, T; Fukatsu, T; Hara, J; Miyake-Takagi, K; Nagakura, A; Niimura, M; Takagi, N; Takeo, S; Tanonaka, K | 1 |
Ando, T; Ichikawa, T; Kajihara, H; Kikuchi, K; Miyake-Takagi, K; Omino, K; Takagi, N; Takeo, S; Tanonaka, K | 1 |
Kameyama, T; Mamiya, T; Nabeshima, T; Shiotani, T; Tanaka, T; Yamada, K | 1 |
Kamei, C; Tasaka, K; Tsujimoto, S | 1 |
6 other study(ies) available for nefiracetam and Age-Related Memory Disorders
Article | Year |
---|---|
Nefiracetam activation of CaM kinase II and protein kinase C mediated by NMDA and metabotropic glutamate receptors in olfactory bulbectomized mice.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Denervation; Disease Models, Animal; Enzyme Activation; Hippocampus; Long-Term Potentiation; Male; Memory Disorders; Mice; Nootropic Agents; Olfactory Bulb; Organ Culture Techniques; Phosphorylation; Protein Kinase C; Pyrrolidinones; Receptor, Metabotropic Glutamate 5; Receptors, Glutamate; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate | 2009 |
Persistent effects of delayed treatment with nefiracetam on the water maze task in rats with sustained cerebral ischemia.
Topics: Animals; Brain; Brain Ischemia; Cyclic AMP-Dependent Protein Kinases; Male; Maze Learning; Memory Disorders; Pyrrolidinones; Rats; Rats, Wistar | 2003 |
A possible mechanism for improvement by a cognition-enhancer nefiracetam of spatial memory function and cAMP-mediated signal transduction system in sustained cerebral ischaemia in rats.
Topics: Animals; Brain Ischemia; Cognition; Cyclic AMP; Male; Memory; Memory Disorders; Nootropic Agents; Pyrrolidinones; Rats; Rats, Wistar; Signal Transduction; Spatial Behavior | 2003 |
Effects of nefiracetam on cerebral adenylyl cyclase activity in rats with microsphere embolism-induced memory dysfunction.
Topics: Animals; Behavior, Animal; Blotting, Western; Body Weight; Brain Ischemia; Cell Membrane; Colforsin; Cyclic AMP; Disease Models, Animal; Dose-Response Relationship, Drug; Embolism; Escape Reaction; GTP-Binding Proteins; Male; Maze Learning; Memory Disorders; Microspheres; Neuroprotective Agents; Pyrrolidinones; Rats; Rats, Wistar; Time Factors | 2003 |
Improvement by nefiracetam of beta-amyloid-(1-42)-induced learning and memory impairments in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amyloid beta-Peptides; Animals; Avoidance Learning; Biogenic Monoamines; Choline O-Acetyltransferase; Corpus Striatum; Dopamine; Frontal Lobe; Hippocampus; Homovanillic Acid; Learning; Learning Disabilities; Male; Maze Learning; Memory Disorders; Motor Activity; Peptide Fragments; Psychotropic Drugs; Pyrrolidinones; Rats; Rats, Wistar | 1999 |
Effects of cholinergic drugs and cerebral metabolic activators on memory impairment in old rats.
Topics: Acetylcholine; Aging; Animals; Benzoquinones; Brain; Central Nervous System Agents; gamma-Aminobutyric Acid; Learning; Male; Memory Disorders; Morpholines; Pantothenic Acid; Parasympathomimetics; Pyrrolidinones; Rats; Rats, Inbred Strains; Ubiquinone | 1990 |